P/GF-1 COMPANION DIAGNOSTIC METHODS AND PRODUCTS

The present disclosure relates to, among other things, methods for determining whether a subject receiving treatment with a drug has obtained an efficacious blood level of the drug. Moreover, the present disclosure also relates to methods of determining whether a subject predisposed to or suffering...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TYNER, JOAN, D, HAWKSWORTH, DAVID, J, MCKEEGAN, EVELYN, MARY, LAIRD, DON, M, PUCCI, DOMINICK, L, ZIEMANN, ROBERT, N, DATWYLER, SAUL, SOGIN, DAVID, C, LESNIEWSKI, RICHARD, R
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	TYNER, JOAN, D HAWKSWORTH, DAVID, J MCKEEGAN, EVELYN, MARY LAIRD, DON, M PUCCI, DOMINICK, L ZIEMANN, ROBERT, N DATWYLER, SAUL SOGIN, DAVID, C LESNIEWSKI, RICHARD, R
description	The present disclosure relates to, among other things, methods for determining whether a subject receiving treatment with a drug has obtained an efficacious blood level of the drug. Moreover, the present disclosure also relates to methods of determining whether a subject predisposed to or suffering from a disease will benefit from treatment with a drug, and the response of a subject receiving treatment (e.g., such as for cancer) by monitoring biomarkers of angiogenesis. In particular, the disclosure relates to P/GF-1 companion diagnostic methods and products. La présente invention concerne, entre autres, des procédés de détermination pour savoir si un sujet recevant un traitement avec un médicament a obtenu une concentration sanguine efficace du médicament. En outre, la présente invention concerne également des procédés de détermination pour savoir si un sujet prédisposé ou souffrant d'une maladie bénéficiera d'un traitement avec un médicament, ainsi que la réponse d'un sujet recevant un traitement (par exemple contre le cancer) en surveillant des biomarqueurs d'angiogenèse. En particulier, l'invention concerne des procédés de diagnostic par compagnon P/GF-1 et des produits.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2009155381A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2009155381A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2009155381A13</originalsourceid><addsrcrecordid>eNrjZDAI0Hd30zVUcPb3DXD08_T3U3DxdHT38w8O8XRW8HUN8fB3CVZw9HNRCAjydwl1DgnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBgaWhqamxhaGjobGxKkCAKJ4Jvk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>P/GF-1 COMPANION DIAGNOSTIC METHODS AND PRODUCTS</title><source>esp@cenet</source><creator>TYNER, JOAN, D ; HAWKSWORTH, DAVID, J ; MCKEEGAN, EVELYN, MARY ; LAIRD, DON, M ; PUCCI, DOMINICK, L ; ZIEMANN, ROBERT, N ; DATWYLER, SAUL ; SOGIN, DAVID, C ; LESNIEWSKI, RICHARD, R</creator><creatorcontrib>TYNER, JOAN, D ; HAWKSWORTH, DAVID, J ; MCKEEGAN, EVELYN, MARY ; LAIRD, DON, M ; PUCCI, DOMINICK, L ; ZIEMANN, ROBERT, N ; DATWYLER, SAUL ; SOGIN, DAVID, C ; LESNIEWSKI, RICHARD, R</creatorcontrib><description>The present disclosure relates to, among other things, methods for determining whether a subject receiving treatment with a drug has obtained an efficacious blood level of the drug. Moreover, the present disclosure also relates to methods of determining whether a subject predisposed to or suffering from a disease will benefit from treatment with a drug, and the response of a subject receiving treatment (e.g., such as for cancer) by monitoring biomarkers of angiogenesis. In particular, the disclosure relates to P/GF-1 companion diagnostic methods and products. La présente invention concerne, entre autres, des procédés de détermination pour savoir si un sujet recevant un traitement avec un médicament a obtenu une concentration sanguine efficace du médicament. En outre, la présente invention concerne également des procédés de détermination pour savoir si un sujet prédisposé ou souffrant d'une maladie bénéficiera d'un traitement avec un médicament, ainsi que la réponse d'un sujet recevant un traitement (par exemple contre le cancer) en surveillant des biomarqueurs d'angiogenèse. En particulier, l'invention concerne des procédés de diagnostic par compagnon P/GF-1 et des produits.</description><language>eng ; fre</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091223&DB=EPODOC&CC=WO&NR=2009155381A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091223&DB=EPODOC&CC=WO&NR=2009155381A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TYNER, JOAN, D</creatorcontrib><creatorcontrib>HAWKSWORTH, DAVID, J</creatorcontrib><creatorcontrib>MCKEEGAN, EVELYN, MARY</creatorcontrib><creatorcontrib>LAIRD, DON, M</creatorcontrib><creatorcontrib>PUCCI, DOMINICK, L</creatorcontrib><creatorcontrib>ZIEMANN, ROBERT, N</creatorcontrib><creatorcontrib>DATWYLER, SAUL</creatorcontrib><creatorcontrib>SOGIN, DAVID, C</creatorcontrib><creatorcontrib>LESNIEWSKI, RICHARD, R</creatorcontrib><title>P/GF-1 COMPANION DIAGNOSTIC METHODS AND PRODUCTS</title><description>The present disclosure relates to, among other things, methods for determining whether a subject receiving treatment with a drug has obtained an efficacious blood level of the drug. Moreover, the present disclosure also relates to methods of determining whether a subject predisposed to or suffering from a disease will benefit from treatment with a drug, and the response of a subject receiving treatment (e.g., such as for cancer) by monitoring biomarkers of angiogenesis. In particular, the disclosure relates to P/GF-1 companion diagnostic methods and products. La présente invention concerne, entre autres, des procédés de détermination pour savoir si un sujet recevant un traitement avec un médicament a obtenu une concentration sanguine efficace du médicament. En outre, la présente invention concerne également des procédés de détermination pour savoir si un sujet prédisposé ou souffrant d'une maladie bénéficiera d'un traitement avec un médicament, ainsi que la réponse d'un sujet recevant un traitement (par exemple contre le cancer) en surveillant des biomarqueurs d'angiogenèse. En particulier, l'invention concerne des procédés de diagnostic par compagnon P/GF-1 et des produits.</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAI0Hd30zVUcPb3DXD08_T3U3DxdHT38w8O8XRW8HUN8fB3CVZw9HNRCAjydwl1DgnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBgaWhqamxhaGjobGxKkCAKJ4Jvk</recordid><startdate>20091223</startdate><enddate>20091223</enddate><creator>TYNER, JOAN, D</creator><creator>HAWKSWORTH, DAVID, J</creator><creator>MCKEEGAN, EVELYN, MARY</creator><creator>LAIRD, DON, M</creator><creator>PUCCI, DOMINICK, L</creator><creator>ZIEMANN, ROBERT, N</creator><creator>DATWYLER, SAUL</creator><creator>SOGIN, DAVID, C</creator><creator>LESNIEWSKI, RICHARD, R</creator><scope>EVB</scope></search><sort><creationdate>20091223</creationdate><title>P/GF-1 COMPANION DIAGNOSTIC METHODS AND PRODUCTS</title><author>TYNER, JOAN, D ; HAWKSWORTH, DAVID, J ; MCKEEGAN, EVELYN, MARY ; LAIRD, DON, M ; PUCCI, DOMINICK, L ; ZIEMANN, ROBERT, N ; DATWYLER, SAUL ; SOGIN, DAVID, C ; LESNIEWSKI, RICHARD, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2009155381A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2009</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>TYNER, JOAN, D</creatorcontrib><creatorcontrib>HAWKSWORTH, DAVID, J</creatorcontrib><creatorcontrib>MCKEEGAN, EVELYN, MARY</creatorcontrib><creatorcontrib>LAIRD, DON, M</creatorcontrib><creatorcontrib>PUCCI, DOMINICK, L</creatorcontrib><creatorcontrib>ZIEMANN, ROBERT, N</creatorcontrib><creatorcontrib>DATWYLER, SAUL</creatorcontrib><creatorcontrib>SOGIN, DAVID, C</creatorcontrib><creatorcontrib>LESNIEWSKI, RICHARD, R</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TYNER, JOAN, D</au><au>HAWKSWORTH, DAVID, J</au><au>MCKEEGAN, EVELYN, MARY</au><au>LAIRD, DON, M</au><au>PUCCI, DOMINICK, L</au><au>ZIEMANN, ROBERT, N</au><au>DATWYLER, SAUL</au><au>SOGIN, DAVID, C</au><au>LESNIEWSKI, RICHARD, R</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>P/GF-1 COMPANION DIAGNOSTIC METHODS AND PRODUCTS</title><date>2009-12-23</date><risdate>2009</risdate><abstract>The present disclosure relates to, among other things, methods for determining whether a subject receiving treatment with a drug has obtained an efficacious blood level of the drug. Moreover, the present disclosure also relates to methods of determining whether a subject predisposed to or suffering from a disease will benefit from treatment with a drug, and the response of a subject receiving treatment (e.g., such as for cancer) by monitoring biomarkers of angiogenesis. In particular, the disclosure relates to P/GF-1 companion diagnostic methods and products. La présente invention concerne, entre autres, des procédés de détermination pour savoir si un sujet recevant un traitement avec un médicament a obtenu une concentration sanguine efficace du médicament. En outre, la présente invention concerne également des procédés de détermination pour savoir si un sujet prédisposé ou souffrant d'une maladie bénéficiera d'un traitement avec un médicament, ainsi que la réponse d'un sujet recevant un traitement (par exemple contre le cancer) en surveillant des biomarqueurs d'angiogenèse. En particulier, l'invention concerne des procédés de diagnostic par compagnon P/GF-1 et des produits.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_WO2009155381A1
source	esp@cenet
subjects	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
title	P/GF-1 COMPANION DIAGNOSTIC METHODS AND PRODUCTS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A33%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TYNER,%20JOAN,%20D&rft.date=2009-12-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2009155381A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true